WPD Pharmaceuticals Inc. (CSE:WBIO)
Canada flag Canada · Delayed Price · Currency is CAD
0.0700
0.00 (0.00%)
At close: May 8, 2025

WPD Pharmaceuticals Balance Sheet

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Cash & Equivalents
0.010.090.020.31.242.95
Cash & Short-Term Investments
0.010.090.020.31.242.95
Cash Growth
-93.49%260.85%-92.10%-75.69%-58.02%118857.60%
Other Receivables
0.040.030.050.030.040.22
Receivables
0.040.030.050.030.040.22
Prepaid Expenses
00-0.060.030.01
Restricted Cash
---1.410.63-
Total Current Assets
0.060.120.081.81.943.18
Property, Plant & Equipment
---0.070.090.09
Long-Term Investments
0.240.22---0.48
Other Intangible Assets
----0.660.33
Total Assets
0.290.350.081.862.684.07
Accounts Payable
0.460.530.451.620.80.61
Accrued Expenses
0.040.050.090.160.03-
Short-Term Debt
0.02--1.030.090.19
Current Portion of Leases
---0.020.020.06
Current Unearned Revenue
---2.430.63-
Other Current Liabilities
0.020.020.020.67--
Total Current Liabilities
0.540.60.555.921.580.86
Long-Term Debt
0.370.3----
Total Liabilities
0.910.90.555.921.580.86
Common Stock
17.1517.0817.0817.0817.0815.83
Retained Earnings
-22.14-22.01-21.93-25.79-20.17-12.64
Comprehensive Income & Other
4.374.374.374.654.190.02
Shareholders' Equity
-0.62-0.56-0.48-4.061.113.21
Total Liabilities & Equity
0.290.350.081.862.684.07
Total Debt
0.390.3-1.040.120.25
Net Cash (Debt)
-0.38-0.220.02-0.741.122.7
Net Cash Growth
-----58.34%-
Net Cash Per Share
-0.08-0.050.01-0.160.2519.73
Filing Date Shares Outstanding
4.644.544.544.544.544.54
Total Common Shares Outstanding
4.644.544.544.544.544.46
Working Capital
-0.49-0.48-0.48-4.120.362.32
Book Value Per Share
-0.13-0.12-0.11-0.890.240.72
Tangible Book Value
-0.62-0.56-0.48-4.060.452.88
Tangible Book Value Per Share
-0.13-0.12-0.11-0.890.100.65
Machinery
---0.10.10.04
Source: S&P Global Market Intelligence. Standard template. Financial Sources.